{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T07:08:05Z","timestamp":1777446485977,"version":"3.51.4"},"posted":{"date-parts":[[2021,10,13]]},"group-title":"Infectious Diseases (except HIV\/AIDS)","reference-count":23,"publisher":"openRxiv","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2021,10,15]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>While Coronavirus disease 2019 (Covid-19) vaccines are highly effective, breakthrough infections are occurring. Booster vaccinations have recently received emergency use authorization (EUA) for certain populations but are restricted to homologous mRNA vaccines. We evaluated homologous and heterologous booster vaccination in persons who had received an EUA Covid-19 vaccine regimen.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>\n                    In this phase 1\/2 open-label clinical trial conducted at ten U.S. sites, adults who received one of three EUA Covid-19 vaccines at least 12 weeks prior to enrollment and had no reported history of SARS-CoV-2 infection received a booster injection with one of three vaccines (Moderna mRNA-1273 100-\u03bcg, Janssen Ad26.COV2.S 5\u00d710\n                    <jats:sup>10<\/jats:sup>\n                    virus particles, or Pfizer-BioNTech BNT162b2 30-\u03bcg; nine combinations). The primary outcomes were safety, reactogenicity, and humoral immunogenicity on study days 15 and 29.\n                  <\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>458 individuals were enrolled: 154 received mRNA-1273, 150 received Ad26.CoV2.S, and 153 received BNT162b2 booster vaccines. Reactogenicity was similar to that reported for the primary series. Injection site pain, malaise, headache, and myalgia occurred in more than half the participants. Booster vaccines increased the neutralizing activity against a D614G pseudovirus (4.2-76-fold) and binding antibody titers (4.6-56-fold) for all combinations; homologous boost increased neutralizing antibody titers 4.2-20-fold whereas heterologous boost increased titers 6.2-76-fold. Day 15 neutralizing and binding antibody titers varied by 28.7-fold and 20.9-fold, respectively, across the nine prime-boost combinations.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Homologous and heterologous booster vaccinations were well-tolerated and immunogenic in adults who completed a primary Covid-19 vaccine regimen at least 12 weeks earlier.<\/jats:p>\n                  <jats:p>\n                    (Funded by National Institute of Allergy and Infectious Diseases;\n                    <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/ClinicalTrials.gov\">Clinical Trials.gov<\/jats:ext-link>\n                    number,\n                    <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT04889209\">NCT04889209<\/jats:ext-link>\n                    )\n                  <\/jats:p>\n                <\/jats:sec>","DOI":"10.1101\/2021.10.10.21264827","type":"posted-content","created":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T20:40:03Z","timestamp":1634157603000},"source":"Crossref","is-referenced-by-count":61,"title":["Heterologous SARS-CoV-2 Booster Vaccinations \u2013 Preliminary Report"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9989-6772","authenticated-orcid":false,"given":"Robert L.","family":"Atmar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsten E.","family":"Lyke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meagan E.","family":"Deming","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa A.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela R.","family":"Branche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hana M.","family":"El Sahly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina A.","family":"Rostad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith M.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard E.","family":"Rupp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark J.","family":"Mulligan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca C.","family":"Brady","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Robert W.","family":"Frenck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mart\u00edn","family":"B\u00e4cker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelica C.","family":"Kottkamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tara M.","family":"Babu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kumaravel","family":"Rajakumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srilatha","family":"Edupuganti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Dobryzynski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine M.","family":"Posavad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet I.","family":"Archer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonja","family":"Crandon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seema U.","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Szydlo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jillian","family":"Zemanek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara P. Dominguez","family":"Islas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth R.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2686-8380","authenticated-orcid":false,"given":"Mehul S.","family":"Suthar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Juliana","family":"McElrath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian B.","family":"McDermott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah E.","family":"O\u2019Connell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C.","family":"Montefiori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Eaton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen M.","family":"Neuzil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David S.","family":"Stephens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul C.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John H.","family":"Beigel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the DMID 21-0012 Study Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2021101803200802000_2021.10.10.21264827v2.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2034577"},{"key":"2021101803200802000_2021.10.10.21264827v2.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2035389"},{"key":"2021101803200802000_2021.10.10.21264827v2.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2101544"},{"key":"2021101803200802000_2021.10.10.21264827v2.4","unstructured":"CDC. COVID Data Tracker: COVID-19 Vaccinations in the United States. https:\/\/covid.cdc.gov\/covid-data-tracker\/#vaccinations_vacc-total-admin-rate-total. Accessed October 9, 2021."},{"key":"2021101803200802000_2021.10.10.21264827v2.5","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7031e2"},{"key":"2021101803200802000_2021.10.10.21264827v2.6","doi-asserted-by":"crossref","unstructured":"Rosenberg ES , Holtgrave DR , Dorabawila V , Conroy M , Greene D , Lutterloh E , et al. New COVID-19 Cases and Hospitalizations Among Adults, by Vaccination Status \u2014 New York, May 3\u2013July 25, 2021. MMWR Morb Mortal Wkly Rep 2021;70.","DOI":"10.15585\/mmwr.mm7034e1"},{"key":"2021101803200802000_2021.10.10.21264827v2.7","doi-asserted-by":"crossref","unstructured":"Nanduri S , Pilishvili T , Derado G , Soe MM , Dollard P , Wu H , et al. Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant \u2014 National Healthcare Safety Network, March 1\u2013August 1, 2021. MMWR Morb Mortal Wkly Rep 2021;70.","DOI":"10.15585\/mmwr.mm7034e3"},{"key":"2021101803200802000_2021.10.10.21264827v2.8","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7034e4"},{"key":"2021101803200802000_2021.10.10.21264827v2.9","doi-asserted-by":"publisher","DOI":"10.1101\/2021.08.09.21261290"},{"key":"2021101803200802000_2021.10.10.21264827v2.10","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01540-1"},{"key":"2021101803200802000_2021.10.10.21264827v2.11","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01377-8"},{"key":"2021101803200802000_2021.10.10.21264827v2.12","doi-asserted-by":"crossref","unstructured":"Cromer D , Steain M , Reynaldi A , Schlub TE , Wheatley AK , Juno JA , et al. SARS-CoV-2 variants: levels of neutralisation required for protective immunity. medRxiv 2021. DOI: https:\/\/doi.org\/10.1101\/2021.08.11.21261876.","DOI":"10.1101\/2021.08.11.21261876"},{"key":"2021101803200802000_2021.10.10.21264827v2.13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2113468"},{"key":"2021101803200802000_2021.10.10.21264827v2.14","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01527-y"},{"key":"2021101803200802000_2021.10.10.21264827v2.15","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01449-9"},{"key":"2021101803200802000_2021.10.10.21264827v2.16","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01464-w"},{"key":"2021101803200802000_2021.10.10.21264827v2.17","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01694-9"},{"key":"2021101803200802000_2021.10.10.21264827v2.18","unstructured":"FDA. Food and Drug Administration. Toxicity grading scale for healthy adult and adolescent volunteers enrolled in preventive vaccine clinical trials: Guidance for industry. (https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/toxicity-grading-scale-healthy-adult-and-adolescent-volunteers-enrolled-preventive-vaccine-clinical). September 2007. Accessed September 6, 2021."},{"key":"2021101803200802000_2021.10.10.21264827v2.19","doi-asserted-by":"publisher","DOI":"10.1126\/science.abj4176"},{"key":"2021101803200802000_2021.10.10.21264827v2.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2021.03.002"},{"key":"2021101803200802000_2021.10.10.21264827v2.21","doi-asserted-by":"crossref","unstructured":"Sadoff J , Le Gars M , Cardenas V , Shukarev G , Vaissiere N , Heerwegh D , et al. Durability of antibody responses elicited by a single dose of Ad26.COV2.S and substantial increase following late boosting. MedRxiv 2021. DOI: https:\/\/doi.org\/10.1101\/2021.08.25.21262569","DOI":"10.1101\/2021.08.25.21262569"},{"key":"2021101803200802000_2021.10.10.21264827v2.22","doi-asserted-by":"crossref","unstructured":"Wu K , Choi A , Koch M , LingZhi M , Hill A , Nunna N , et al. Preliminary Analysis of Safety and Immunogenicity of a SARS-CoV-2 Variant Vaccine Booster. MedRxiv 2021. DOI: https:\/\/doi.org\/10.1101\/2021.05.05.21256716","DOI":"10.1101\/2021.05.05.21256716"},{"key":"2021101803200802000_2021.10.10.21264827v2.23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2108891"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2021.10.10.21264827","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T14:27:20Z","timestamp":1768487240000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2021.10.10.21264827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,13]]},"references-count":23,"URL":"https:\/\/doi.org\/10.1101\/2021.10.10.21264827","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1056\/nejmoa2116414","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2021,10,13]]},"subtype":"preprint"}}